Algernon Neuroscience Inc. — Regulation A 1-A
Algernon Neuroscience Inc. of Vancouver, A1 filed a Regulation A 1-A with the SEC on 2025-01-24. Aggregate offering: $5.0M (Tier 2). Industry: Other.
Offering
- Filed: 2025-01-24
- Form: 1-A
- Accession: 0001062993-25-001035
- Tier: Tier 2
- Total aggregate offering: $5.0M
- Issuer portion: $5.0M
- Price per security: $0.5000
- Securities offered: Equity (common or preferred stock)
- Broker-dealer CRD: 329071
- Audit status: Audited
- Auditor: Smythe LLP
- Jurisdictions: 128 states/territories
Issuer
- CIK: 0001959708
- Organized in: A1
- Incorporated: 2022
- Address: 400-601 West Broadway, Vancouver, A1, V5Z 4C2
- Phone: 604-398-4175
Financial snapshot (as filed)
- Total assets: $40K
- Cash & equivalents: $1
- Total liabilities: $1.7M
- Stockholder equity: $-1.6M
- Net income: $-752K
People (2)
| Name | Role | Location |
|---|
| James Kinley | Chief Financial Offficer | Vancouver, A1 |
| James Kinley | Signer | Vancouver, A1 |
Other Reg A filings by this issuer (6)
More